The University of California, Irvine (UCI) Cancer Center was established in 1989 as a university-based cancer center. In 1994, it became an NCI-designated cancer center, and it achieved comprehensive cancer center status in 1997. Soon after, it was renamed in honor of the Chao family as the Chao Family Comprehensive Cancer Center (CFCCC), operating fully integrated research, prevention, diagnostic, treatment, and rehabilitation programs.
The Center fosters bench-to-bedside research, with programs ranging from basic science research to clinical trials. The mandate for the entire range of programs is to translate the findings of basic research into treatments that can benefit patients. Clinical research at CFCCC focuses on breast, skin, colon, liver, oral, pancreatic, and prostate cancer, and includes prevention. The Center is deeply involved in a national test program investigating the effectiveness of promising new cancer prevention drugs at several sites across the country. This work involves the design of early-phase clinical trials to assess the cancer prevention potential of a variety of agents, many of which target specific molecules known to be active in precancerous conditions.
Read more about the Chao Family Comprehensive Cancer Center.
University of California, Irvine
Director
Building 56, Rt. 81, Room 209
Orange, CA 92868
Associate Director for Administration and Finance
Associate Director for Cancer Health Disparities & Community Engagement
Associate Director for Cancer Research Education & Training